SBI Securities’s DNA X Inc SONM Stock Holding History

SBI Securities’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1K	Hold	214	–	–	﹤0.01%	2773
2026 Q1	$862	Hold	214	–	–	﹤0.01%	2714
2025 Q4	$674	Sell	214 -1	-0.5%	-$9	﹤0.01%	2767
2025 Q3	$2.33K	Buy	215 +173	+412%	+$2.01K	﹤0.01%	2362
2025 Q2	$932	Buy	42 +6	+17%	+$148	﹤0.01%	2710
2025 Q1	$1.4K	Hold	36	–	–	﹤0.01%	2443
2024 Q4	$2.06K	Buy	+36	New	+$2.15K	﹤0.01%	2303

Other funds holding SONM

CWM

C2C Wealth Management Scottsdale, Arizona $128M AUM 22.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SBI Securities's SONM Position: Q2 2026 in Review

SBI Securities held its DNA X Inc (SONM) position steady in Q2 2026 at 214 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2773.

SBI Securities first reported a position in SONM in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.33K in Q3 2025. 8 funds tracked by Wall St. Rank hold SONM as of Q2 2026.

SBI Securities held 214 shares of DNA X Inc worth $1.1K as of Q2 2026.
SBI Securities left its DNA X Inc share count unchanged in Q2 2026.
DNA X Inc made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2773 holding.
SBI Securities first reported a position in DNA X Inc in Q4 2024 and has held it in 7 quarters since.
SBI Securities's DNA X Inc position peaked at $2.33K in Q3 2025.
8 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.